BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17891529)

  • 1. Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast.
    Londero V; Zuiani C; Furlan A; Nori J; Bazzocchi M
    Radiol Med; 2007 Sep; 112(6):863-76. PubMed ID: 17891529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonographically guided biopsy of suspicious microcalcifications of the breast: a pilot study.
    Soo MS; Baker JA; Rosen EL; Vo TT
    AJR Am J Roentgenol; 2002 Apr; 178(4):1007-15. PubMed ID: 11906892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy.
    Suh YJ; Kim MJ; Kim EK; Moon HJ; Kwak JY; Koo HR; Yoon JH
    Br J Radiol; 2012 Aug; 85(1016):e349-56. PubMed ID: 22422382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonographic detection and sonographically guided biopsy of breast microcalcifications.
    Soo MS; Baker JA; Rosen EL
    AJR Am J Roentgenol; 2003 Apr; 180(4):941-8. PubMed ID: 12646433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
    Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
    J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
    VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
    Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US-guided 14G core needle biopsy: comparison between underestimated and correctly diagnosed breast cancers.
    Kim H; Youk JH; Kim JA; Gweon HM; Jung WH; Son EJ
    Asian Pac J Cancer Prev; 2014; 15(7):3179-83. PubMed ID: 24815467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
    Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy.
    Zuiani C; Londero V; Bestagno A; Puglisi F; Di Loreto C; Bazzocchi M
    Radiol Med; 2005; 110(5-6):589-602. PubMed ID: 16437044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound Demonstration of Mammographically Detected Microcalcifications in Patients with Ductal Carcinoma in situ of the Breast.
    Nagashima T; Hashimoto H; Oshida K; Nakano S; Tanabe N; Nikaido T; Koda K; Miyazaki M
    Breast Cancer; 2005; 12(3):216-20. PubMed ID: 16110292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Columnar Cell Lesions and Atypical Ductal Hyperplasia by Ultrasound-Guided Core Biopsy: Findings Associated with Underestimation of Breast Carcinoma.
    Ahn HS; Jang M; Kim SM; Yun BL; Kim SW; Kang EY; Park SY
    Ultrasound Med Biol; 2016 Jul; 42(7):1457-63. PubMed ID: 27067419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of lobular neoplasia identified on percutaneous core breast biopsy.
    Bauer VP; Ditkoff BA; Schnabel F; Brenin D; El-Tamer M; Smith S
    Breast J; 2003; 9(1):4-9. PubMed ID: 12558663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonographic findings of pure ductal carcinoma in situ.
    Lee MH; Ko EY; Han BK; Shin JH; Ko ES; Hahn SY
    J Clin Ultrasound; 2013 Oct; 41(8):465-71. PubMed ID: 23949917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic findings of high-grade and non-high-grade ductal carcinoma in situ of the breast.
    Park JS; Park YM; Kim EK; Kim SJ; Han SS; Lee SJ; In HS; Ryu JH
    J Ultrasound Med; 2010 Dec; 29(12):1687-97. PubMed ID: 21098839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy.
    Hoorntje LE; Schipper ME; Peeters PH; Bellot F; Storm RK; Borel Rinkes IH
    Ann Surg Oncol; 2003 Aug; 10(7):748-53. PubMed ID: 12900365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underestimation of invasive lesions in patients with ductal carcinoma in situ of the breast diagnosed by ultrasound-guided biopsy: a comparison between patients with and without HER2/neu overexpression.
    Chang WC; Hsu HH; Yu JC; Ko KH; Peng YJ; Tung HJ; Chang TH; Hsu GC
    Eur J Radiol; 2014 Jun; 83(6):935-941. PubMed ID: 24666513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary?
    Cawson JN; Malara F; Kavanagh A; Hill P; Balasubramanium G; Henderson M
    Cancer; 2003 Jan; 97(2):345-51. PubMed ID: 12518358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomas of the breast: factors associated with underestimation.
    Boufelli G; Giannotti MA; Ruiz CA; Barros N; Chala LF; Maesaka JY; Goncalves R; Bresciani BH; Vianna P; Soares JM; Baracat EC; Filassi JR
    Eur J Cancer Prev; 2018 Jul; 27(4):310-314. PubMed ID: 28296665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.